![David Arkowitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Arkowitz
Directeur/Membre du Conseil chez
IBIO, INC.
Fortune : 23 345 $ au 31/08/2026
Profil
Mr. David A. Arkowitz is an Independent Director at iBio, Inc. and a Chief Financial Officer at Alkeus Pharmaceuticals, Inc. He is on the Board of Directors at iBio, Inc. and Yumanity, Inc. Mr. Arkowitz was previously employed as an Independent Director by Kineta, Inc., a Chief Financial & Accounting Officer by Seres Therapeutics, Inc., an Independent Director by Yumanity Therapeutics, Inc., an Independent Director by F-star Therapeutics, Inc., an Independent Director by Proteostasis Therapeutics, Inc., a Chief Financial & Accounting Officer by Flexion Therapeutics, Inc., an Independent Director by F-Star Therapeutics, Inc. (United States), a Chief Operating & Financial Officer by Visterra, Inc., a Chief Financial Officer & General Manager by Mascoma Corp., a Chief Financial & Business Officer by AMAG Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by Idenix Pharmaceuticals LLC, a VP & Controller-Research & Development Division by Merck & Co., Inc., a Vice President-Finance & Business Development by Merck Frosst Canada Ltd., a Controller by Merck Research Laboratories Massachusetts LLC, and a Director-Financial Planning & Analysis by Merck-Medco Managed Care LLC.
He also served on the board at Aegerion Pharmaceuticals, Inc. and ImpactRx, Inc. He received his undergraduate degree from Brandeis University and an MBA from Columbia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IBIO, INC. 0,05 % | 01/09/2026 | 18 382 ( 0,05 % ) | 23 345 $ | 31/08/2026 |
Postes actifs de David Arkowitz
| Sociétés | Poste | Début |
|---|---|---|
| IBIO, INC. | Directeur/Membre du Conseil | 25/11/2024 |
Alkeus Pharmaceuticals, Inc.
 Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Directeur Financier/CFO | 01/10/2024 |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Directeur/Membre du Conseil | - |
Anciens postes connus de David Arkowitz
| Sociétés | Poste | Fin |
|---|---|---|
| KINETA, INC. | Directeur/Membre du Conseil | 30/06/2025 |
| SERES THERAPEUTICS, INC. | Directeur Financier/CFO | 15/03/2024 |
| F-STAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/03/2023 |
| YUMANITY THERAPEUTICS | Directeur/Membre du Conseil | 01/12/2022 |
| FLEXION THERAPEUTICS, INC. | Directeur Financier/CFO | 31/05/2021 |
Formation de David Arkowitz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health-care sector custom research and promotional consultancy services | Commercial Services |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Mascoma Corp.
 Mascoma Corp. BiotechnologyHealth Technology Develops technology for abundant biomass conversion | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Visterra, Inc.
 Visterra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Merck-Medco Managed Care LLC
 Merck-Medco Managed Care LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Frosst Canada Ltd.
 Merck Frosst Canada Ltd. Pharmaceuticals: MajorHealth Technology Produces pharmaceutical preparations | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for maternal & women health, anemia management and cancer supportive care | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
iBio, Inc.
 iBio, Inc. Pharmaceuticals: OtherHealth Technology Engages in the development and commercialization of vaccines and therapeutic proteins | Health Technology |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Alkeus Pharmaceuticals, Inc.
Alkeus Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Provides degenerative retinal diseases treatment services | Health Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yumanity, Inc.
Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Provides transforming drug discovery for neurodegenerative diseases services | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
Yumanity Therapeutics, Inc.
 Yumanity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kineta, Inc.
 Kineta, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
